SCHEMBL23629690

SCHEMBL23629690

C1=CC2=NCC=CC2=CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165813 0.80
SCHEMBL1533841 0.71 PPARA (0.32) PPARA
SCHEMBL29103257 0.70
SCHEMBL9559243 0.70
SCHEMBL2051934 0.67
SCHEMBL2505127 0.67
SCHEMBL8691695 0.65
SCHEMBL29257177 0.65
SCHEMBL5089685 0.65
SCHEMBL17838918 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3847159-A2 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE Magenta Therapeutics, Inc. (US) 2021-07-14 EP claimed
WO-2022121774-A1 COMPOSITE MAGNETORHEOLOGICAL FLUID 深圳博海新材料技术有限公司 2022-06-16 WO disclosed
EP-3847159-A2 ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE Magenta Therapeutics, Inc. (US) 2021-07-14 EP disclosed